About pharma question and answers
Minor: Grievances connected to the product not meeting non-significant high-quality attributes, or harm to secondary packaging or shortages etcetera.Any interaction, prepared or verbal, gained concerning the good quality, packing directly from any traders or product company and promoting workers or another these problems shall be considered as a Cu